Total Synthesis of (()-Quinolizidine 217A
H-N [(M + H - N
)+] 284.1862, found 284.1875.
J . Org. Chem., Vol. 63, No. 26, 1998 9915
C
15
H
25
O
4
N
3
2
2
tr a n s-2-[(1,3-Dioxolan -2-yl)m eth yl]-6-(4-h ydr oxybu tyl)-
p ip er id in e (28). A solution of 23 (26.8 mg, 0.0860 mmol) in
Anal. Calcd for C15 3: C, 57.86; H, 8.09; N, 13.49.
25 4
H O N
Found: C, 57.83; H, 8.03; N, 13.20.
6 6
C D (1.0 mL) in a sealable NMR tube was degassed using
three freeze/thaw cycles and then sealed under vacuum. The
tube were heated in an oil bath to 120 °C for 68.5 h, when
NMR spectroscopic analysis showed complete formation of the
Eth yl (Z)-10-(1,3-Dioxola n -2-yl)-9-h yd r oxy-6-m eth yl-4-
d ecen oa te (24). DIBALH (0.63 mL, 0.941 mmol, 1.5 M
solution in toluene) was added to a cold (-78 °C) solution of
1
tetrahydropyridine 27 [ H NMR (C
)
(
1
2
1
6
D
6
, 300 MHz) δ 0.95 (t, J
2
2 2
1 (0.157 g, 0.784 mmol) in dry CH Cl (3.7 mL). After 1 h,
7.1 Hz, 3H), 1.10-2.40 (m, 14H), 3.34-3.65 (m, 4H), 3.67
methanol (0.1 mL) and water (0.1 mL) were added sequen-
tially. After being warmed to room temperature, the mixture
was diluted with ether (5 mL) and MgSO was added. After
4
br, 1H), 3.96 (q, J ) 7.1 Hz, 2H), 5.48 (dd, J ) 3.7, 6.6 Hz,
H); 13C NMR (CDCl
, 90 MHz) δ 14.65, 19.69, 21.80, 28.83,
3
9.45, 34.17, 39.73, 43.30, 55.05, 60.28, 65.07 (overlap), 103.69,
67.85, 173.43]. After cooling the tube to 0 °C and unsealing,
being stirred vigorously for 1 h, the mixture was filtered and
the filter cake was washed with ether (20 mL). The filtrate
was concentrated to give 0.154 g (97% crude) of the lactol as
colorless oil. Potassium bis(trimethysilyl)amide (3.64 mL, 1.82
mmol, 0.5 M solution in toluene) was added to a suspension
the contents were washed from the tube with dichloromethane
10 mL) and the solvent was removed under reduced pressure
(
to give 27 as a colorless oil. A solution of 27 in dry THF (1.5
mL) was added to a suspension of LiAlH4 (32.6 mg, 0.860
mmol) in dry THF (1.5 mL) at -78 °C, followed by the addition
of trimethylaluminum (0.43 mL, 0.860 mmol, 2.0 M solution
in hexane).16 After 30 min, the solution was warmed to -40
1
4
of [Ph
3
P(CH
2 3 2
) CO Et]Br (26, 824 mg, 1.82 mmol) in dry THF
(
°
4.4 mL) at 0 °C. After 30 min, the mixture was cooled to -78
C and the lactol in dry THF (9.0 mL) was added. After 30
min at -78 °C, the mixture was warmed to 0 °C, stirred for 2
h, then quenched with saturated aqueous NH Cl (20 mL), and
extracted with ether (20 mL × 3). The organic extracts were
dried (Na SO ) and concentrated. The residue was purified
chromatographed (3:1 hexane/ethyl acetate) to give 0.124 g
52%) of the title compound as colorless oil, which was found
°
C for 1 h, then -20 °C for 1 h, and finally 0 °C for 1 h. The
4
mixture was diluted with ether (2 mL) and treated with
sodium fluoride (68 mg, 1.63 mmol) followed by the cautious
dropwise addition of water (0.05 mL). After 15 min, the
resulting slurry was filtered through Celite, washing the filter
pad with ether (20 mL). The combined filtrates were dried
2
4
(
1
to be a 1:1.2 mixture of diastereomers (both Z-alkenes) by H
NMR spectroscopy. R
(
(Na
2 4
SO ) and concentrated. The residue was chromatographed
f
) 0.38 (1:1 hexane/ethyl acetate); IR
1 1
-
(90:9:1, CHCl /MeOH/NH OH) to give 14.2 mg (68%) of 28 as
neat) 3504 (br), 1732 (s) cm ; H NMR (C
6
D
6
, 300 MHz) δ
3
4
a colorless oil, which was found to be a single diastereomer
0
1
3
.90 (d, J ) 6.6 Hz, 3H × 1.2/2.2), 0.91 (d, J ) 6.5 Hz, 3H ×
/2.2), 0.947 (t, J ) 7.2 Hz, 3H × 1.2/2.2), 0.954 (t, J ) 7.1 Hz,
H × 1/2.2), 1.15-1.60 (m, 4H), 1.80-1.84 (m, 2H), 2.15-2.50
1
13
by H and C NMR spectroscopy. R
f
) 0.12 (90:9:1, CHCl
3
/
,
-
1
1
MeOH/NH OH); IR (neat) 3332 (br) cm ; H NMR (CDCl
4
3
3
00 MHz) δ 1.24-1.74 (m, 13H), 1.95 (ddd, J ) 5.5, 8.7, 14.2
Hz, 1H), 2.64 (br s, 2H), 2.80-2.95 (m, 1H), 3.10-3.25 (m, 1H),
.64 (t, J ) 6.5 Hz, 2H), 3.80-4.01 (m, 4H), 4.93 (t, J ) 5.0
(
m, 5H), 2.75 (d, J ) 2.5 Hz, 1H × 1/2.2), 2.83 (d, J ) 2.7 Hz,
1
7
4
H × 1.2/2.2), 3.18-3.44 (m, 4H), 3.93 (m, 1H), 3.94 (q, J )
.2 Hz, 2H × 1/2.2), 3.95 (q, J ) 7.1 Hz, 2H × 1.2/2.2), 4.86-
.90 (m, 1H), 5.12-5.18 (m, 1H), 5.23-5.32 (m, 1H); 13C NMR
3
1
3
Hz, 1H); C NMR (CDCl , 90 MHz) δ 20.09, 22.56, 31.22,
3
3
1
2
2.03, 32.99, 34.19, 37.80, 47.42, 50.71, 62.84, 64.87, 65.10,
04.00; MS (CI, NH
42 (20), 224 (8), 171 (12), 170 (75); HRMS (CI, NH
(
3
3
CDCl , 100 MHz) δ 14.45, 21.48, 21.59, 23.27, 31.86, 31.94,
+
) m/z (rel intense) 244 [(M + H) , 39],
3.18, 33.41, 34.76, 35.33, 35.45, 40.36, 60.50, 64.93, 65.13,
8.05, 68.25, 103.81, 126.46, 126.49, 137.61, 137.69, 179,71;
3
) calcd for
6
3
+
+
C H O H [(M + H) ] 244.1913, found 244.1917.
MS (CI, NH
2
3
) m/z (rel intense) 301 [(M + H) ,23], 230 (33),
13 25
3
14 (14), 213 (38), 200 (18), 199 (100), 196 (14), 195 (20), 186
Assign m en t of th e Rela tive Con figu r a tion of 28. Ac-
cording to literature precedent, the CHN methine protons in
simple cis-2,6-dialkylpiperidines typically appear at δ 2.4-2.7
ppm, whereas these protons appear at approximately δ 2.8-
+
(
3
12), 185 (76); HRMS (CI, NH
01.2015, found 301.2018. Anal. Calcd for C16
H, 9.40. Found: C, 63.60; H, 9.49.
3
) calcd for C16
H
28
O
5
H [(M + H) ]
28 5
H O : C, 63.97;
3
.3 ppm in the trans diastereomers.17 In 28, the appearance
Eth yl (Z)-9-Azid o-10-(1,3-d ioxola n -2-yl)-6-m eth yl-4-d e-
cen oa te (25). Methanesulfonyl chloride (0.278 g, 0.19 mL, 2.43
mmol) was added to a cold (-40 °C) solution of 24 (0.146 g,
of the two CHN methine protons at ca. δ 2.9 and 3.2 ppm is
most consistent with the trans-2,6 diastereomer. In the other
possible diastereomer (29, see below), these protons appear
at ca. δ 2.5 and 2.7 ppm, consistent with the cis-2,6 diastere-
omer.
0
.486 mmol) and triethylamine (0.270 g, 0.37 mL, 2.67 mmol)
in dry CH Cl (6.7 mL). After 1 h at room temperature, ether
20 mL) was added and the mixture was washed with ice-cold
2
2
(
2
% HCl (20 mL) and then saturated NaHCO
3
(20 mL). The
cis-2-[(1,3-Dioxola n -2-yl)m eth yl]-6-(4-h yd r oxybu tyl)p i-
organic phase was dried (MgSO
4
) and concentrated to give pale
6 6
p er id in e (29). A solution of 23 (25.3 mg, 0.0813 mmol) in C D
yellow oil that was dissolved in dry THF (2.4 mL) and treated
with tetra-n-butylammonium azide (1.94 mL, 1 M solution in
THF, 1.94 mmol). After being stirred for 17 h at room
temperature, the mixture was diluted with dichloromethane
and washed with water (20 mL) and then the organic phase
(1.0 mL) in a sealable NMR tube was degassed and heated as
above. After cooling the tube to 0 °C and unsealing, the
contents were washed from the tube with benzene (10 mL)
and the solvent was removed under reduced pressure to give
2 2
27 as a colorless oil. A solution of 27 in dry CH Cl (0.5 mL)
was dried (Na
2
SO
4
) and concentrated. The residue was chro-
was treated with DIBALH (0.27 mL, 0.41 mmol, 1.5 M solution
in toluene) at -78 °C.16 After 30 min, the solution was warmed
to -40 °C for 1 h, then -20 °C for 1 h, and finally 0 °C for 1
h. The mixture was diluted with ether (2 mL) and treated with
sodium fluoride (68 mg, 1.63 mmol) followed by the cautious
dropwise addition of water (0.05 mL). After 15 min, the
resulting slurry was filtered through Celite, washing the filter
pad with ether (20 mL). The combined filtrates were dried
matographed (10:1 hexane/ethyl acetate) to give 0.137 g (87%)
of the title compound as colorless oil, which was found to be
an inseparable 1:1.2 mixture of diastereomers (both with the
1
Z-alkene geometry) by H NMR spectroscopy. R
f
) 0.48 (3:1
-
1
1
hexane/ethyl acetate); IR (neat) 2102 (s), 1732 (s) cm ; H
NMR (C
6
D
6
, 400 MHz) δ 0.82 (d, J ) 6.6 Hz, 3H × 1/2.2), 0.83
(
1
(
7
d, J ) 6.2 Hz, 3H × 1.2/2.2), 0.96 (t, J ) 7.1 Hz, 3H), 1.00-
.46 (m, 4H), 1.69-1.75 (m, 1H), 1.86-1.94 (m, 1H), 2.14 -2.35
(Na
(90:9:1, CHCl
2
SO
4
) and concentrated. The residue was chromatographed
/MeOH/NH OH) to give 5.5 mg (28%) of 27 as a
m, 5H), 3.31-3.37 (m, 2H), 3.43-3.53 (m, 3H), 3.96 (q, J )
3
4
.1 Hz, 2H), 4.91-4.94 (m, 1H), 5.01-5.07 (m, 1H), 5.21-5.29
colorless oil, which was found to be a single diastereomer by
1
3
1
13
(
m, 1H); C NMR (C
6
D
6
, 100 MHz) δ 14.66, 21.76, 21.88, 23.76,
2.09, 32.19, 33.51, 33.60, 34.04, 34.12, 34.91, 39.53, 39.60,
9.87, 60.08, 60.48, 65.11, 65.25, 102.62, 127.51, 127.58,
37.41, 137.52, 172.72; MS (CI, NH ) m/z (rel intense) 298 [(M
) , 100], 282 (2), 254 (2), 227 (8), 226 (38); HRMS
H and C NMR spectroscopy. R
f
-
) 0.21 (90:9:1, CHCl
3
/MeOH/
, 300 MHz)
1 1
3
5
1
+
(
NH
4
OH); IR (neat) 3334 (br) cm ; H NMR (CDCl
3
δ 0.98-1.85 (m, 14H), 2.13 (br, 2H), 2.43-2.55 (m, 1H), 2.69-
3
2.80 (m, 1H), 3.64 (t, J ) 6.5 Hz, 2H), 3.80-4.02 (m, 4H), 4.97
+
13
H - N
2
(dd, J ) 4.1, 5.5 Hz, 1H); C NMR (CDCl , 90 MHz) δ 22.21,
3
+
CI, NH
3
) calcd for C16
98.2018, found 298.2023. Anal. Calcd for C16
9.06; H, 8.36; N, 12.91. Found: C, 59.25; H, 8.16; N, 12.88.
H
27
O
4
N
3
H-N
2
[(M + H - N
2
) ]
24.97, 32.39, 32.96, 33.19, 36.98, 40.92, 53.68, 57.02, 62.83,
64.87, 65.12, 103.82; MS (CI, NH ) m/z (rel intense) 244 [(M
+ H) , 100], 242 (16), 171 (11), 170 (56); HRMS (CI, NH ) calcd
2
5
H
27
O
4
N
3: C,
3
+
3